Abstract:Due to their excellent capabilities in photodynamic therapy (PDT) and aggregation-induced emission, (AIE) photosensitizers have attracted a great deal of attention. However, the poor water solubilities of current AIE photosensitizers limit their widespread in vivo application and PDT productivity. AIE photosensitizers with triphenylamine as electron-donating moiety and pyridine as electron-absorbing group can enhance the D–A effort, thus improving the intramolecular charge transfer (ICT) and extending the emission wavelength. At the same time, Δ E st was reduced and intersystem crossing processes was promoted due to the D–A effect of the photosensitizers, thus increasing the probability of ROS generation. Herein, a dual-organelle targeted and viscosity-sensitive infrared AIE photosensitizer (NES-OH) with a D–A structure was developed and synthesized. The NES-OH had good water solubility and good linear relationship with concentration. The NES-OH exhibited bright fluorescence at 620 nm with a quantum yield of 66.75% and had high 1 O 2 generation efficiency, as well as good biocompatibility and photostability. The NES-OH can target mitochondria and lysosomes and also monitor lysosomes and mitochondrial viscosity changes in real time or in situ in living cells. More interestingly, in the acidic environment of cancer cells, the structure of the NES-OH changed with the appearance of specific morpholine groups, leading to the targeting of lysosomes and further distinguishing and detecting normal and cancer cells. The in vitro and in vivo study demonstrated that the NES-OH can inhibit tumor growth efficiently upon light exposure. This work constructed an effective photosensitizer for diagnosing and treating cancers and evaluating PDT efficacy.

Evaluation of the value of Synechococcus 7942 as a sensitizer for photo-sonodynamic therapy against breast cancer

Analysis of the in Vivo and in Vitro Effects of Photodynamic Therapy on Breast Cancer by Using a Sensitizer, Sinoporphyrin Sodium

IR-780 Dye as a Sonosensitizer for Sonodynamic Therapy of Breast Tumor

Photodynamic Damage of Carcinophotorin on Breast Cancer Cells MDA-MB-231 and Its Mechanism

Rationale of Combined PDT and SDT Modalities for Treating Cancer Patients in Terminal Stage—The Proper Use of Photosensitizer: A Reply

Recent progress in sono-photodynamic cancer therapy: From developed new sensitizers to nanotechnology-based efficacy-enhancing strategies

Dual-targeted and viscosity-sensitive infrared AIE photosensitizer based on tumor microenvironmental response for photodynamic cancer therapy

Sinoporphyrin Sodium, a Novel Sensitizer for Photodynamic and Sonodynamic Therapy

Synthesis, Characterization, and Biological Evaluation of a Porphyrin-Based Photosensitizer and Its Isomer for Effective Photodynamic Therapy Against Breast Cancer

Efficient Polysulfide-Based Nanotheranostics for Triple-Negative Breast Cancer: Ratiometric Photoacoustics Monitored Tumor Microenvironment-Initiated H<sub>2</sub>S Therapy

A series of photosensitizers with incremental positive electric charges for photodynamic antitumor therapy

Rationally designed near-infrared AIEgens photosensitizer for cell membrane-targeted photo-driven theranostics

Efficient Polysulfide‐Based Nanotheranostics for Triple‐Negative Breast Cancer: Ratiometric Photoacoustics Monitored Tumor Microenvironment‐Initiated H 2 S Therapy

The molecular design of and challenges relating to sensitizers for cancer sonodynamic therapy

Engineered cyanobacteria-Fe3O4 hybrid system as oxygen generator and photosensitizer production factory for synergistic cancer PDT-immunotherapy

A Silicon-Rhodamine-Based Heavy-Atom-Free Photosensitizer for Mitochondria-targeted Photodynamic Therapy

Reconstructing Tumor Microenvironment Using Photoresponsive Cyanobacteria to Reversal Chemoresistance for Robust Chemotherapy

Comparative study of two kinds of repeated photodynamic therapy strategies in breast cancer by using a sensitizer, sinoporphyrin sodium.

Molecular Engineering to Accelerate Cancer Cell Discrimination and Boost AIE-active Type I Photosensitizer for Photodynamic Therapy under Hypoxia

In vitro and in vivo evaluation of a chlorin-based photosensitizer KAE® for cancer treatment

Phycocyanin Nanoparticle As a Novel Sonosensitizer for Tumor Sonodynamic Therapy of Michigan Cancer Foundation-7 Cells in Vitro.